MedPath

Clinical Trial on Ayurvedic Tablet Kanyalohadi Vati foR Primary Dysmenorrhea

Phase 3
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Registration Number
CTRI/2023/10/058399
Lead Sponsor
Dr Sonal Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group 16-32 years

-patient with regular cycles complaining of painful menstruation for at least three consecutive cycles

Exclusion Criteria

-Pelvic pathology – Known case of Fibroid, Adenomyosis, Endometriosis, PID, Menorrhagia, Malignancy.

-Patients with intrauterine contraceptive devices or on contraceptive pills.

-Congenital anomalies of reproductive system.

-Metabolic disorders – known case of Diabeties Mellitus , Hypertension , Thyroid dysfunction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
this study is done for symptomatic management of pain in primary dysmenorrhea with ayurvedic tablet kanyalohadi vatiTimepoint: 30 Days
Secondary Outcome Measures
NameTimeMethod
Symptomatic Relief In The SymptomsTimepoint: 90 Days;this medicine will help to get rid of painful menses experience , & will not lead to effect the day to day activityTimepoint: 90 days
© Copyright 2025. All Rights Reserved by MedPath